These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 37359941)
1. Updated Incidence, Treatment and Survival of a Nationwide Cohort of Patients with Peritoneal Metastases of Unknown Origin. Rijken A; Loef C; van de Wouw YAJ; van Erning FN; de Hingh IHJT Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):67-73. PubMed ID: 37359941 [TBL] [Abstract][Full Text] [Related]
2. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin. Thomassen I; Verhoeven RH; van Gestel YR; van de Wouw AJ; Lemmens VE; de Hingh IH Eur J Cancer; 2014 Jan; 50(1):50-6. PubMed ID: 24011935 [TBL] [Abstract][Full Text] [Related]
3. Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database. Rijken A; Bakkers C; Klümpen HJ; van der Geest LG; de Vos-Geelen J; van Erning FN; de Hingh IHJT Eur J Surg Oncol; 2023 Aug; 49(8):1436-1443. PubMed ID: 36898900 [TBL] [Abstract][Full Text] [Related]
4. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study. Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733 [TBL] [Abstract][Full Text] [Related]
5. Peritoneal Metastases from Extraperitoneal Primary Tumors: Incidence, Treatment, and Survival from a Nationwide Database. Rijken A; Galanos LJK; Burger JWA; Nienhuijs SW; van Erning FN; de Hingh IHJT Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):60-66. PubMed ID: 37359924 [TBL] [Abstract][Full Text] [Related]
6. Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort. Koemans WJ; Lurvink RJ; Grootscholten C; Verhoeven RHA; de Hingh IH; van Sandick JW Gastric Cancer; 2021 Jul; 24(4):800-809. PubMed ID: 33495964 [TBL] [Abstract][Full Text] [Related]
7. Incidence, risk factors, treatment, and survival of ovarian metastases of colorectal origin: a Dutch population-based study. Bakkers C; van der Meer R; Roumen RM; Lurvink RJ; Lemmens VE; van Erning FN; de Hingh IH Int J Colorectal Dis; 2020 Jun; 35(6):1035-1044. PubMed ID: 32157379 [TBL] [Abstract][Full Text] [Related]
8. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon. Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061 [TBL] [Abstract][Full Text] [Related]
9. Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival. Rijken A; Pape M; Simkens GA; de Hingh IHJT; Luyer MDP; van Sandick JW; van Laarhoven HWM; Verhoeven RHA; van Erning FN Int J Cancer; 2024 Mar; 154(6):992-1002. PubMed ID: 37916797 [TBL] [Abstract][Full Text] [Related]
10. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada. Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957 [TBL] [Abstract][Full Text] [Related]
11. Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases. Simkens GA; Razenberg LG; Lemmens VE; Rutten HJ; Creemers GJ; de Hingh IH Eur J Surg Oncol; 2016 Jun; 42(6):794-800. PubMed ID: 27055946 [TBL] [Abstract][Full Text] [Related]
12. Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site-a Review. Bhatt A; Mishra S; Glehen O Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):15-29. PubMed ID: 37359927 [TBL] [Abstract][Full Text] [Related]
13. Synchronous peritoneal metastases from lung cancer: incidence, associated factors, treatment and survival: a Dutch population-based study. Lurvink RJ; Rijken A; Bakkers C; Aarts MJ; Kunst PWA; van de Borne BE; van Erning FN; de Hingh IHJT Clin Exp Metastasis; 2021 Jun; 38(3):295-303. PubMed ID: 33738641 [TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands. Burg L; Timmermans M; van der Aa M; Boll D; Rovers K; de Hingh I; van Altena A J Gynecol Oncol; 2020 Sep; 31(5):e58. PubMed ID: 32808491 [TBL] [Abstract][Full Text] [Related]
15. A population-based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer. de Boer NL; Rovers K; Burger JWA; Madsen EVE; Brandt-Kerkhof ARM; Kok NFM; de Wilt JHW; de Reuver PH; Bos A; de Hingh IHJT; Verhoef C Cancer Med; 2020 Aug; 9(16):5851-5859. PubMed ID: 32614506 [TBL] [Abstract][Full Text] [Related]
16. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes. Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493 [TBL] [Abstract][Full Text] [Related]
17. Site-specific survival rates for cancer of unknown primary according to location of metastases. Hemminki K; Riihimäki M; Sundquist K; Hemminki A Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409 [TBL] [Abstract][Full Text] [Related]
18. The prognostic relevance of histologic subtype in appendiceal adenocarcinoma. Legué LM; van Erning FN; Creemers GJ; de Hingh IHJT; Lemmens VEPP; Huysentruyt CJ Eur J Surg Oncol; 2020 Mar; 46(3):433-438. PubMed ID: 31668980 [TBL] [Abstract][Full Text] [Related]
19. Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study. Rijken A; van de Vlasakker VCJ; Simkens GA; Rovers KP; van Erning FN; Koopman M; Verhoef C; de Wilt JHW; de Hingh IHJT Clin Exp Metastasis; 2023 Aug; 40(4):289-298. PubMed ID: 37209222 [TBL] [Abstract][Full Text] [Related]
20. Unknown primary carcinoma in the Netherlands: decrease in incidence and survival times remain poor between 2000 and 2012. Schroten-Loef C; Verhoeven RHA; de Hingh IHJT; van de Wouw AJ; van Laarhoven HWM; Lemmens VEPP Eur J Cancer; 2018 Sep; 101():77-86. PubMed ID: 30031970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]